Skip to main content

Table 1 Demographic characteristics of the 34 patients with EPE

From: Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study

No Age (y) Sex Peripheral blood Pleural effusion Diagnosis
WBC (× 109/L) LYM (× 109/L) EO (× 109/L) WBC (× 109/L) EO (%) RBC (× 106/L) LDH (U/L) ADA (U/L) GLU (mmol/L) Protein (g/L) CEA (ng/mL)
1 48 M 4.7 0.3 0.6 4.4 13.5 1466 128 6.7 3.02 43.2 4.80 PPI
2 29 M 12.7 1.6 0.3 5.8 30.2 1703 587 19.1 3.19 43.1 1.74 PPI
3 63 F 16.7 1.8 5.8 8.0 22.5 449 667 10.8 5.95 47.4 0.30 PPI
4 48 M 11.3 1.2 0.6 4.8 19.0 2200 189 2.8 7.79 39.8 1.67 IPE
5 49 M 4.6 1.4 0.4 3.8 15.2 5277 201 24.0 5.15 35.6 4.31 IPE
6 45 M 8.6 0.7 0.4 4.7 21.2 3251 234 20.0 4.84 43.2 3.34 IPE
7 52 F 8.7 1.5 0.3 7.4 18.9 549 321 17.0 4.97 34.2 2.67 IPE
8 49 F 10.4 1.1 0.8 5.5 12.4 1583 214 19.9 4.40 32.8 3.40 IPE
9 35 F 5.7 1.4 0.3 6.6 46.5 5262 421 20.4 5.61 49.6 0.95 PPE
10 25 M 9.7 2.4 0.7 12.9 67.5 1232 365 6.5 5.45 53.4 1.54 PPE
11 67 F 14.6 0.5 0 4.1 19.2 5637 145 1.7 8.02 33.9 2.15 PPE
12 46 M 8.1 0.9 0.1 2.6 12.8 4788 558 44.7 5.68 53.4 1.18 TPE
13 83 F 6.5 1.5 0 0.4 15.7 4581 130 2.1 6.90 27.5 1.67 HR-PE
14 33 F 7.6 0.6 0.1 0.8 15.3 186 116 0.1 5.48 28.8 1.32 CTD-PE
15 66 M 5.2 1.2 0 0.3 25.5 2,986,738 90 1.8 7.45 37.5 1.53 Haemothorax
16 70 M 5.2 0.6 0 2.4 11.6 20,185 111 3.8 6.37 32.4 2.08 Pulmonary embolism
17 70 M 4.9 0.9 0.1 3.2 23.5 2339 1402 13.2 6.11 39.5 148.20 MPE
18 57 M 9.9 2.3 1 1.1 55.0 15,319 712 10.3 6.66 48.2 162.20 MPE
19 74 M 7.7 1.2 1.5 0.3 11.0 192 326 3.1 5.99 35.2 49.04 MPE
20 45 M 6.8 1.1 0.3 1.3 11.6 7422 352 7.2 6.34 53.7 81.15 MPE
21 44 F 6.8 1.2 0.2 0.1 12.5 2573 403 4.2 5.80 60.7 2087.0 MPE
22 88 M 8.6 2.5 0.4 0.9 12.0 4951 563 3.3 4.52 49.3 384.50 MPE
23 47 F 4.9 1.1 0.2 1.5 10.5 13,366 172 3.1 7.52 40.6 289.70 MPE
24 58 M 14.8 1.1 0.1 0.4 23.5 5052 310 7.8 5.57 44.3 339.40 MPE
25 81 M 21.4 1.9 0.1 1.0 13.5 2859 182 7.6 6.04 182.9 2.60 MPE
26 59 F 5.1 1.2 0.2 0.2 14.5 25,654 424 4.2 5.19 40.5 0.94 MPE
27 61 M 6.2 0.9 0 0.6 11.5 5787 215 7.0 7.24 53.9 17.39 MPE
28 55 F 8.8 2.2 0.2 0.2 10.0 7097 217 3.0 4.44 40.2 1.27 MPE
29 67 F 9.5 1.5 0.3 4.5 11.0 320,000 327 4.2 8.34 52.0 10.97 MPE
30 76 M 6.4 1.0 0.1 1.1 10.5 3000 232 4.0 8.01 42.9 4.07 MPE
31 56 F 3.2 0.6 0.5 2.2 31.0 1752 265 8.1 7.83 51.8 1.89 MPE
32 44 M 11.2 1.5 0.6 0.4 22.5 12,315 209 4.0 9.77 49.7 0.46 MPE
33 57 F 9.0 1.8 0.8 7.7 63.0 216,195 1126 29.3 4.32 62.3 0.91 MPE
34 71 M 8.11 0.9 0.5 6.5 24.0 91,620 645 27.6 6.48 49.4 0.99 MPE
  1. Abbreviations: EPE eosinophilic pleural effusion, WBC white blood cell, LYM lymphocyte, EO eosinophil, RBC red blood cell, LDH lactate dehydrogenase, ADA adenosine deaminase, GLU glucose, CEA carcinoembryonic antigen, PPI pleural parasitic infestation, IPE idiopathic pleural effusion, PPE parapneumonic effusion, TPE tuberculous pleural effusion, HR-PE heart related pleural effusion, CTD-PE Connective tissue diseases- pleural effusion, MPE malignant pleural effusion